| |
| |
|
| Insider
Information: |
Moed Samuel J |
| Relationship: |
SVP, Strat Plan & Anal... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,014 |
|
|
Indirect Shares
|
600 |
|
|
| Direct
Value |
$1,386,636 |
|
|
|
Indirect Value
|
$26,826 |
|
|
| Total
Shares |
31,614 |
|
|
| Total
Value |
$1,413,462 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP, Strat Plan & Anal... |
2015-03-13 |
31,014 |
2015-03-13 |
600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & AnalysisOffi |
• – – |
2012-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,658 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & AnalysisOffi |
• – – |
2012-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
600 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,936 |
11,594 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-03-03 |
4 |
D |
$37.15 |
$26,414 |
D/D |
(711) |
10,883 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-03-07 |
4 |
D |
$37.53 |
$220,113 |
D/D |
(5,865) |
20,754 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,311 |
26,619 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,425 |
25,308 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
25,754 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-05-01 |
4 |
D |
$39.72 |
$90,125 |
D/D |
(2,269) |
23,485 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-06-04 |
4 |
S |
$47.38 |
$2,790,587 |
D/D |
(58,898) |
24,687 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• • – |
2013-06-04 |
4 |
OE |
$22.73 |
$1,544,273 |
D/D |
60,100 |
83,585 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,491 |
28,687 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,209 |
40,530 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-03 |
4 |
D |
$53.49 |
$352,446 |
D/D |
(6,589) |
35,798 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,043 |
36,841 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
708 |
37,549 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-06 |
4 |
D |
$55.56 |
$43,003 |
D/D |
(774) |
36,775 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-10 |
4 |
D |
$56.14 |
$49,684 |
D/D |
(885) |
37,595 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
532 |
38,480 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,173 |
37,948 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
42,595 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-05-01 |
4 |
D |
$49.52 |
$128,405 |
D/D |
(2,593) |
40,002 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2014-07-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
31,900 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2015-02-06 |
4 |
OE |
$22.14 |
$618,547 |
D/D |
27,938 |
59,838 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Strat Plan & Analysis |
• – – |
2015-02-06 |
4 |
S |
$60.15 |
$1,291,988 |
D/D |
(21,478) |
38,360 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
